During the past decade, Gävle hospital conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 5 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gävle hospital" #1 sponsor was "Uppsala University" with 7 trials, followed by "Karolinska Institutet" with 5 trials sponsored, "Lund University Hospital" with 3 trials sponsored, "Norwegian University of Science and Technology" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gävle hospital" #1 collaborator was "The Swedish Research Council" with 5 trials as a collaborator, "Oslo University Hospital" with 4 trials as a collaborator, "Gävle Hospital" with 3 trials as a collaborator, "Karolinska Institutet" with 3 trials as a collaborator and "Karolinska University Hospital" with 3 trials as a collaborator. Other collaborators include 102 different institutions and companies that were collaborators in the rest 89 trials.

According to Clinical.Site data, the most researched conditions in "Gävle hospital" are "Myocardial Infarction" (3 trials), "Atrial Fibrillation" (2 trials), "Coronary Artery Disease" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials) and "Rectal Cancer" (2 trials). Many other conditions were trialed in "Gävle hospital" in a lesser frequency.

Most popular intervention types in "Gävle hospital" are "Drug" (18 trials), "Other" (6 trials), "Procedure" (6 trials), "Device" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (2 trials), "45 Gy in 30 fractions" (1 trials), "60 Gy in 40 fractions" (1 trials), ": A support program to facilitate implementation of evidence-based practice for postoperative urinary retention" (1 trials) and "ACEI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gävle hospital" are 37 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Gävle hospital". undefined are not yet recruiting, 8 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Gävle hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gävle hospital, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 18 trials that are defined as “Not Applicable".